Immediate Impact
13 by Nobel laureates 24 from Science/Nature 63 standout
Citing Papers
Inhibition of PCSK9 potentiates immune checkpoint therapy for cancer
2020 StandoutNature
Peptide-Based Vaccines: Current Progress and Future Challenges
2019 Standout
Works of T.J. Eberlein being referenced
Breast and ovarian cancer-specific cytotoxic T lymphocytes recognize the same HER2/neu-derived peptide.
1995
Author Peers
| Author | Last Decade | Papers | Cites | |||||
|---|---|---|---|---|---|---|---|---|
| T.J. Eberlein | 574 | 284 | 139 | 461 | 369 | 59 | 1.2k | |
| Marc Van den Eynde | 911 | 317 | 323 | 239 | 191 | 89 | 1.5k | |
| E. Douglas Holyoke | 964 | 320 | 413 | 205 | 191 | 69 | 1.6k | |
| Maria Grazia Diodoro | 430 | 247 | 170 | 197 | 269 | 41 | 1.1k | |
| R. Cavaliere | 517 | 231 | 126 | 408 | 164 | 49 | 1.5k | |
| Joan Somja | 530 | 283 | 190 | 390 | 197 | 54 | 1.5k | |
| Marcus Tan | 1092 | 327 | 374 | 520 | 259 | 52 | 1.7k | |
| Hongnan Mo | 976 | 216 | 409 | 361 | 327 | 53 | 1.4k | |
| Young Wha Koh | 871 | 193 | 544 | 316 | 239 | 81 | 1.6k | |
| Débora De Melo Gagliato | 908 | 165 | 506 | 266 | 485 | 33 | 1.5k | |
| Herman Bril | 434 | 232 | 156 | 256 | 159 | 56 | 1.1k |
All Works
Loading papers...